Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 4/20 | 0.69 |
| ▸ | MAPT | P10636 | 3/20 | 0.69 |
| ▸ | TP53 | P04637 | 2/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.69 |
| ▸ | XDH | P47989 | 2/20 | 0.69 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.69 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.69 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.69 |
| ▸ | ATM | Q13315 | 2/20 | 0.69 |
| ▸ | KDM1A | O60341 | 2/20 | 0.69 |
| ▸ | HPGD | P15428 | 1/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.69 |
| ▸ | PKM | P14618 | 1/20 | 0.69 |
| ▸ | NPC1 | O15118 | 1/20 | 0.69 |
| ▸ | CA12 | O43570 | 1/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.69 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.69 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.69 |
| ▸ | TSHR | P16473 | 1/20 | 0.69 |
| ▸ | CA4 | P22748 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4466273 | 1.00 | CYP19A1 (0.69) | CYP19A1MAPTTP53CYP3A4XDH | |
| SCHEMBL2124058 | 0.87 | CYP19A1 (0.68) | CYP19A1MAPTTP53CYP3A4XDH | |
| SCHEMBL12878874 | 0.84 | CYP19A1 (0.65) | CYP19A1MAPTTP53CYP3A4XDH | |
| Hesperetin SCHEMBL765368 | 0.82 | CYP19A1 (1.00) | CYP19A1MAPTTP53CYP3A4XDH | |
| Hesperetin SCHEMBL29534477 | 0.82 | CYP19A1 (1.00) | CYP19A1MAPTTP53CYP3A4XDH | |
| Hesperetin SCHEMBL29359052 | 0.82 | CYP19A1 (1.00) | CYP19A1MAPTTP53CYP3A4XDH | |
| Hesperetin SCHEMBL31689737 | 0.82 | CYP19A1 (1.00) | CYP19A1MAPTTP53CYP3A4XDH | |
| Hesperetin SCHEMBL39833 | 0.82 | CYP19A1 (1.00) | CYP19A1MAPTTP53CYP3A4XDH | |
| Hesperetin SCHEMBL20929082 | 0.82 | CYP19A1 (1.00) | CYP19A1MAPTTP53CYP3A4XDH | |
| Hesperetin SCHEMBL29484563 | 0.82 | CYP19A1 (1.00) | CYP19A1MAPTTP53CYP3A4XDH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1783193-B1 | ANTIOXIDANT MATERIAL, ANTI-DETERIORATION AGENT AND FOOD OR BEVERAGE | POKKA SAPPORO FOOD & BEVERAGE LTD (JP) | 2016-03-30 | — | — | EP | disclosed |
| US-8247002-B2 | Antioxidant material, anti-deterioration agent and food or beverage | POKKA CORPORATION (JP) | 2012-08-21 | — | — | US | disclosed |
| US-7582675-B2 | Flavonoid compound and process for producing the same | POKKA CORPORATION (JP) | 2009-09-01 | — | — | US | disclosed |
| US-20090175996-A1 | Antioxidant material, anti-deterioration agent and food or beverage | POKKA CORPORATION (JP) | 2009-07-09 | — | — | US | disclosed |
| US-20070244189-A1 | Antioxidant Material, Anti-Deterioration Agent and Food or Beverage | POKKA CORPORATION (JP) | 2007-10-18 | — | — | US | disclosed |
| EP-1783193-A1 | ANTIOXIDANT MATERIAL, ANTI-DETERIORATION AGENT AND FOOD OR BEVERAGE | POKKA CORPORATION (JP) | 2007-05-09 | — | — | EP | disclosed |
| CN-1946830-A | Antioxidant material, anti-deterioration agent and food or beverage | POKKA CORP (JP) | 2007-04-11 | — | — | CN | disclosed |
| US-20060270009-A1 | Flavonoid compound and process for producing the same | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2006-11-30 | — | — | US | disclosed |
| US-7138429-B2 | Flavonoid compound and process for producing the same | JAPAN SCI. TECH. CORP. (JP) | 2006-11-21 | — | — | US | disclosed |
| EP-1369489-B1 | FLAVONOID COMPOUND AND PROCESS FOR PRODUCING THE SAME | JAPAN SCIENCE & TECH CORP (JP) | 2006-08-23 | — | — | EP | disclosed |
| US-20040152762-A1 | Flavonoid compound and process for producing the same | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2004-08-05 | — | — | US | disclosed |
| EP-1369489-A1 | FLAVONOID COMPOUND AND PROCESS FOR PRODUCING THE SAME | Japan Science and Technology Corporation (JP) | 2003-12-10 | — | — | EP | disclosed |
| JP-2002355004-A | LEMON-FERMENTED PRODUCT AND METHOD FOR PRODUCING THE SAME | POKKA CORP | 2002-12-10 | — | — | JP | disclosed |
| JP-2002293778-A | FLAVONOID COMPOUND AND METHOD FOR PRODUCING THE SAME | POKKA CORP | 2002-10-09 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040152762-A1 | Flavonoid compound and process for producing the same | ERG28, TFPI, HES1 | CYP19A1 279/4885MAPT 3583/4885TP53 3131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.